JMD ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nashed, A. L.
Right arrow Articles by Gulley, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nashed, A. L.
Right arrow Articles by Gulley, M. L.
JMD 2003, Vol. 5, No. 2
Copyright © 2003 American Society for Investigative Pathology & Association for Molecular Pathology

Clinical Applications of BCR-ABL Molecular Testing in Acute Leukemia

Amgad L. Nashed*, Kathleen W. Rao*{dagger}{ddagger} and Margaret L. Gulley*

From the Departments of Pathology and Laboratory Medicine, * Pediatrics, {dagger} and Genetics, {ddagger} University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Recent advances in molecular genetics impact the health care and outcome of patients with acute lymphoblastic leukemia (ALL). BCR-ABL, a common molecular defect in adult ALL, is a valuable tumor marker whose detection influences prognosis and clinical management decisions. Molecular methods such as fluorescence in situ hybridization (FISH), reverse-transcriptase polymerase chain reaction (rtPCR), and real-time quantitative rtPCR can be used to detect the chimeric BCR-ABL gene or its transcripts. These molecular assays improve our ability to measure residual disease and to estimate risk of relapse. On the horizon are gene expression profiles that will likely provide additional information beyond what is obtainable with current clinical and laboratory approaches.




This article has been cited by other articles:


Home page
J. Mol. Diagn.Home page
Z. Jobbagy, R. van Atta, K. M. Murphy, J. R. Eshleman, and C. D. Gocke
Evaluation of the Cepheid GeneXpert BCR-ABL Assay
J. Mol. Diagn., April 1, 2007; 9(2): 220 - 227.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
D. P. Kalogianni, V. Bravou, T. K. Christopoulos, P. C. Ioannou, and N. C. Zoumbos
Dry-reagent disposable dipstick test for visual screening of seven leukemia-related chromosomal translocations
Nucleic Acids Res., February 28, 2007; 35(4): e23 - e23.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
E. P. Garcia, L. A. Dowding, L. W. Stanton, and V. I. Slepnev
Scalable Transcriptional Analysis Routine--Multiplexed Quantitative Real-Time Polymerase Chain Reaction Platform for Gene Expression Analysis and Molecular Diagnostics
J. Mol. Diagn., October 1, 2005; 7(4): 444 - 454.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
M. I. Gutierrez, G. Timson, A. K. Siraj, R. Bu, S. Barbhaya, S. Banavali, and K. Bhatia
Single Monochrome Real-Time RT-PCR Assay for Identification, Quantification, and Breakpoint Cluster Region Determination of t(9;22) Transcripts
J. Mol. Diagn., February 1, 2005; 7(1): 40 - 47.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society for Investigative Pathology and the Association for Molecular Pathology.